Abstract:Plasma aldosterone concentration has been usually measured by radioimmunoassay and chemiluminescent enzyme immunoassay which have demonstrated lack of high specificity and variability in assay performances. Liquid chromatography-tandem mass spectrometry is considered to be ideal measurement method of plasma aldosterone, however it takes relatively high cost and measurement time. We recently developed a novel non-competitive chemiluminescent enzyme immunoassay for plasma aldosterone concentrations by the fully automated assay system. We performed clinical validation of diagnostic ability of the new assay-based screening of 344 hypertensive patients including 133 patients with primary aldosterone producing adenoma, 100 patients with bilateral hyperaldosteronism, and 111 patients with essential hypertension. Passing-bablok analysis revealed that the new measurement of plasma aldosterone concentration was significantly correlated and almost equivalent to liquid chromatography-tandem mass spectrometry measurement of aldosterone; the regression slope and intercept were 0.962 and -0.043, and the correlation coefficient was 0.962, which is more similar than radioimmunoassay especially in lower range (< 10 ng/dL). Bland-Altman plot analysis with the mass-spectrometry measurement also demonstrated that both bias and limits of agreement with 95% confidence interval of the automated aldosterone assay were smaller than those of the radioimmunoassay, suggesting smaller systemic errors in the novel measurement. The lowest plasma aldosterone concentration and ratio of aldosterone-over-renin concentrations in aldosterone producing adenoma group were 6.0 ng/dL and 16.3 ng/dL per pg/mL/hr, respectively. We suggest if aldosterone-over-renin concentrations is over 15 ng/dL per pg/mL/hr, the patient should be performed confirmatory test for primary aldosteronism. The novel chemiluminescent enzyme immunoassay is clinically reliable alternative for conventional radioimmunoassay and liquid chromatography-tandem mass spectrometry to provide better throughput and cost-effectiveness in diagnosis of primary aldosteronism from larger number of hypertensive patients.

One-step direct assay for mature-type adrenomedullin with monoclonal antibodies

Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage.

Immunoreactive adrenomedullin in human plasma

Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma

Sandwich immunoassay for adrenomedullin precursor and its practical application

The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma

Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine

Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma

Determination of adalimumab by HPLC with fluorescence detection using the König reaction

Simultaneous Determination of Symmetric Dimethylarginine and Asymmetric Dimethylarginine in Human Plasma by LC-MS/MS

Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue

Newly developed radioimmunoassay for Human Angiotensin-(1-12) measurements in plasma and urine

A novel ELISA system for selective measurement of human adiponectin multimers by using proteases

Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin

Development of a sensitive liquid chromatography-tandem mass spectrometry method for quantification of human plasma arginine vasopressin

Development of anti-Müllerian hormone immunoassay based on biolayer interferometry technology

Determination of Asymmetric Dimethylarginine in Plasma by RP-HPLC

Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects.

Determination of peptidylglycine alpha-amidating monooxygenase activity in human serum by thin-layer chromatography

PS-C22-3: VALIDATION AND CLINICAL EVALUATION OF DIAGNOSTIC ABILITY OF NOVEL CHEMILUMINESCENT ENZYME IMMUNOASSAY OF PLASMA ALDOSTERONE CONCENTRATION.

Simultaneous determination of L -arginine and its mono- and dimethylated metabolites in human plasma by high-performance liquid chromatography–mass spectrometry